evidence based chronic disease self management education programs
Chronic Disease Management vs CD19 CAR‑T: Hope Restored
In the CASTLE phase 1/2 basket trial, 77% of refractory rheumatoid arthritis patients achieved remission after a single CD19 CAR-T infusion, proving that chronic disease management plus CAR-T can restore independence. The trial integrated structured monitoring, multidisciplinary care, and digital education to turn a once-disabled condition into a manageable